These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 19142023)
41. [The significance of angiotensin-converting enzyme inhibitors genotype for ACEi response in patients with chronic allograft nephropathy]. Savin M; Petronić V Srp Arh Celok Lek; 2005; 133(3-4):194-8. PubMed ID: 16206711 [TBL] [Abstract][Full Text] [Related]
42. [Association between angiotensin converting enzyme I/D polymorphism and high-sensitivity C-reactive protein in type 2 diabetic patients with atherosclerosis treated with ramipril]. Wang L; Zhou YL; Lin SG Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):691-5. PubMed ID: 15958311 [TBL] [Abstract][Full Text] [Related]
43. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the plasma angiotensin II levels and the risk of chronic heart failure]. Huang WY; Sun M; Zhou HY Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):198-200. PubMed ID: 16145913 [TBL] [Abstract][Full Text] [Related]
45. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes. Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258 [TBL] [Abstract][Full Text] [Related]
46. Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus. Volkan-Salanci B; Dagdelen S; Alikasifoglu M; Erbas T; Hayran M; Erbas B J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):41-50. PubMed ID: 19286758 [TBL] [Abstract][Full Text] [Related]
47. [The effects of ACE inhibitor treatment and ACE gene polymorphism on erythropoiesis in chronic hemodialysis patients]. Hatano M; Yoshida T; Mimuro T; Kimata N; Tsuchiya K; Sanaka T; Nihei H Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):632-9. PubMed ID: 11195399 [TBL] [Abstract][Full Text] [Related]
48. ACE gene polymorphism in peripheral vascular disease. Başar Y; Salmayenli N; Aksoy M; Seçkin S; Aydin M; Ozkök E Horm Metab Res; 2007 Jul; 39(7):534-7. PubMed ID: 17611909 [TBL] [Abstract][Full Text] [Related]
49. Correlates of ACE activity in macroalbuminuric type 2 diabetic patients treated with chronic ACE inhibition. Nikzamir A; Nakhjavani M; Esteghamati A; Rashidi A Nephrol Dial Transplant; 2008 Apr; 23(4):1274-7. PubMed ID: 17986476 [TBL] [Abstract][Full Text] [Related]
50. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis. Fang W; Oreopoulos DG; Bargman JM Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695 [TBL] [Abstract][Full Text] [Related]
51. Association of the angiotensin-converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients. Huang W; Xie C; Zhou H; Yang T; Sun M Eur J Heart Fail; 2004 Jan; 6(1):23-7. PubMed ID: 15012915 [TBL] [Abstract][Full Text] [Related]
52. Calcium channel antagonists reduce restenosis after percutaneous transluminal angioplasty of an arteriovenous fistula in hemodialysis patients. Doi S; Masaki T; Shigemoto K; Harada S; Yorioka N Ther Apher Dial; 2008 Jun; 12(3):232-6. PubMed ID: 18503701 [TBL] [Abstract][Full Text] [Related]
53. TNF alpha-308 genotype and renin-angiotensin system in hemodialysis patients: an effect on inflammatory cytokine levels? Genctoy G; Altun B; Kiykim AA; Arici M; Erdem Y; Cağlarg M; Yasavul U; Turgan C; Cağlar S Artif Organs; 2005 Feb; 29(2):174-8. PubMed ID: 15670287 [TBL] [Abstract][Full Text] [Related]
54. Insertion/Deletion polymorphism of Angiotensin-converting enzyme as a risk factor for chronic allograft nephropathy. Fedor R; Asztalos L; Löcsey L; Szabó L; Mányiné IS; Fagyas M; Lizanecz E; Tóth A Transplant Proc; 2010; 42(6):2304-8. PubMed ID: 20692468 [TBL] [Abstract][Full Text] [Related]
55. Association of angiotensin-converting enzyme (ACE) gene insertion-deletion polymorphism with spondylarthropathies. Shehab DK; Al-Jarallah KF; Al-Awadhi AM; Al-Herz A; Nahar I; Haider MZ J Biomed Sci; 2008 Jan; 15(1):61-7. PubMed ID: 17713861 [TBL] [Abstract][Full Text] [Related]
56. Angiotensin converting enzyme genotype and chronic allograft nephropathy in protocol biopsies. Hueso M; Alía P; Moreso F; Beltrán-Sastre V; Riera L; González C; Navarro MA; Grinyó JM; Navarro E; Serón D J Am Soc Nephrol; 2004 Aug; 15(8):2229-36. PubMed ID: 15284309 [TBL] [Abstract][Full Text] [Related]
57. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046 [TBL] [Abstract][Full Text] [Related]
58. Influence of angiotensin I-converting enzyme polymorphism on development of post-transplant erythrocytosis in renal graft recipients. Kedzierska K; Kabat-Koperska J; Safranow K; Domański M; Gołembiewska E; Bober J; Bohatyrewicz R; Ciechanowski K Clin Transplant; 2008; 22(2):156-61. PubMed ID: 18339134 [TBL] [Abstract][Full Text] [Related]
59. Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis. Chen FA; Chien CC; Chen YW; Wu YT; Lin CC PLoS One; 2016; 11(11):e0166362. PubMed ID: 27832203 [TBL] [Abstract][Full Text] [Related]
60. [Angiotensin converting enzyme gene polymorphism and type 2 diabetic retinopathy]. Liao L; Lei MX; Chen HL; Guo LJ; Han XY Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):410-3. PubMed ID: 16134592 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]